India approves serum, Bharat Biotech coronavirus vaccines for emergency use; DCGI guarantees 100% security

At the start of the new year, India officially received a coronavirus vaccine when DCGI announced the formal approval of the coronavirus vaccines from Bharat Biotech and Oxford-AstraZeneca.

India’s central drug authority, Drug Controller General of India (DCGI), has issued the formal approval of Oxford-AstraZeneca coronavirus vaccines, manufactured by Serum Institute and Bharat Biotech. VG Somani from DCGI has in this connection stated that both companies have been granted permission for “limited use” in emergency situations after submitting data on their test runs against the coronavirus vaccine.

A coronavirus drug expert committee (SEC) from the Central Drugs Standard Control Organization (CDSCO) made the recommendations, and on the basis of these, the approval was given by DCGI. In connection with the approval of the vaccine, VG Somani stated that experiments with the vaccine had shown that it had a coverage effect of 70%. In addition to the approval of this vaccine, VG Somani informed that Bharat Biotech’s coronavirus vaccine ‘Covaxin’ is safe and provides a robust immune response and he also announced that Covaxin is approved for limited use in emergencies. He further expressed an assurance that if there should be the slightest concern regarding the safety of a vaccine, it will not be approved for use and stressed that the approved vaccines are 110% safe. However, there will usually be mild side effects associated with any vaccine, side effects such as mild fever, pain and allergies. The government-appointed expert panel in India gave Bharat Biotech’s coronacirus vaccine, ‘Covaxin’, and Oxfords ‘Covishield’  secure recommendations for restricted emergency use.

PM MODI CONGRATULATES INDIA
In connection with DCGI’s announcement of the official approval of vaccines from Serum ‘Covishield’ and Bharat Biotech ‘Covaxin’, Prime Minister Modi congratulated India and said that the approval has paved the way for a healthier nation without corona and that it is a crucial turning point in the fight against corona. He also congratulated India on having such skilled and hard-working scientists and tweeted, among other things: ” It would make any Indian proud that the two vaccines that have been approved in emergencies are made in India! This shows the zeal of our scientific community to fulfill the dream of an Aatmanirbhar Bharat whose root is care and compassion. “


Link:
https://www.indiatoday.in/coronavirus-outbreak/vaccine-updates/story/dcgi-serum-oxford-covishield-bharat-biotech-covaxin-approved-india-emergency-cases-2-doses-regime-1755391-2021-01-03

 

 

Comments are closed.